Share this article
Share this article
WINSEN, Germany, May 24, 2021 /PRNewswire/ amg International GmbH ( amg or the Company ), a wholly owned subsidiary of Dublin, Ireland based Q3 Medical Devices Limited (Q3), further establishes its leadership role in the fast-paced development of novel biodegradable implants. The Company announced that it has received CE Mark approval for its second fully biodegradable product, the UNITY-B balloon expandable biodegradable biliary stent (BEBS) for endoscopic use. The UNITY-B will compliment ARCHIMEDES™, the world s first CE approved pancreaticobiliary biodegradable implant.
UNITY-B Balloon Expandable Biodegradable Biliary Stent
The UNITY-B Biodegradable implant was developed as a complimentary biodegradable metallic stent to amg s ARCHIMEDES biodegradable pancreaticobiliary stent, which is currently available in fast, medium, and long-lasting degradation profiles. ARCHIMEDES obtained CE mark approval in 2018 and was subsequently launch